Objectives
Chronic hypertension is the most critical risk factor for cardiovascular disease, heart failure, and stroke.
Approach and Results
Here we show that wild-type mice infused with Angiotensin II develop hypertension, cardiac hypertrophy, perivascular fibrosis and endothelial dysfunction with enhanced Stromal interaction molecule 1 (STIM1) expression in heart and vessels. All these pathologies were significantly blunted in mice lacking STIM1 specifically in smooth muscle (Stim1SMC−/−). Mechanistically, STIM1 up-regulation during Angiotensin II-induced hypertension was associated with enhanced endoplasmic reticulum (ER) stress and smooth muscle STIM1 was required for ER stress-induced vascular dysfunction through TGF-β and NADPH oxidase-dependent pathways. Accordingly, knockout mice for the ER stress pro-apoptotic transcriptional factor, CHOP (CHOP−/−) were resistant to hypertension-induced cardiovascular pathologies. Wild-type mice infused with Angiotensin II, but not Stim1SMC−/− or CHOP−/− mice showed elevated vascular NADPH oxidase activity and reduced phosphorylated endothelial Nitric Oxide Synthase (eNOS), cGMP and nitrite levels.
Conclusion
Thus, smooth muscle STIM1 plays a crucial role in the development of hypertension and associated cardiovascular pathologies and represents a promising target for cardiovascular therapy.